Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study

被引:38
作者
Parrella, Adriana [1 ,2 ]
Braunack-Mayer, Annette [3 ]
Gold, Michael [1 ]
Marshall, Helen [1 ]
Baghurst, Peter [1 ]
机构
[1] Univ Adelaide, Sch Paediat & Reprod Hlth, Discipline Paediat, Adelaide, SA, Australia
[2] Univ Adelaide, Sch Populat Hlth, Discipline Publ Hlth, Adelaide, SA, Australia
[3] Univ Adelaide, Sch Populat Hlth, Adelaide, SA, Australia
基金
英国医学研究理事会;
关键词
Adverse event following immunisation (AEFI); Surveillance; Healthcare provider; Reporting; Qualitative; ASSESSING VACCINE SAFETY; DRUG-REACTIONS; SURVEILLANCE; BARRIERS; SYSTEM; ATTITUDES; CHILDREN; ROUTINE; MODEL;
D O I
10.1186/1472-6963-13-313
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Healthcare provider spontaneous reporting of suspected adverse events following immunisation (AEFI) is central to monitoring post-licensure vaccine safety, but little is known about how healthcare professionals recognise and report to surveillance systems. The aim of this study was explore the knowledge, experience and attitudes of medical and nursing professionals towards detecting and reporting AEFI. Methods: We conducted a qualitative study, using semi-structured, face to face interviews with 13 Paediatric Emergency Department consultants from a tertiary paediatric hospital, 10 General Practitioners, 2 local council immunisation and 4 General Practice nurses, recruited using purposive sampling in Adelaide, South Australia, between December 2010 and September 2011. We identified emergent themes related to previous experience of an AEFI in practice, awareness and experience of AEFI reporting, factors that would facilitate or impede reporting and previous training in vaccine safety. Thematic analysis was used to analyse the data. Results: AEFI reporting was infrequent across all groups, despite most participants having reviewed an AEFI. We found confusion about how to report an AEFI and variability, according to the provider group, as to the type of events that would constitute a reportable AEFI. Participants' interpretation of a "serious" or "unexpected" AEFI varied across the three groups. Common barriers to reporting included time constraints and unsatisfactory reporting processes. Nurses were more likely to have received formal training in vaccine safety and reporting than medical practitioners. Conclusions: This study provides an overview of experience and beliefs of three healthcare professional groups in relation to identifying and reporting AEFI. The qualitative assessment reveals differences in experience and awareness of AEFI reporting across the three professional groups. Most participants appreciated the importance of their role in AEFI surveillance and monitoring the ongoing safety of vaccines. Future initiatives to improve education, such as increased training to health care providers, particularly, medical professionals, are required and should be included in both undergraduate curricula and ongoing, professional development.
引用
收藏
页数:12
相关论文
共 40 条
[1]   The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective [J].
Anderson, Claire ;
Krska, Janet ;
Murphy, Elizabeth ;
Avery, Anthony .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (05) :806-822
[2]  
[Anonymous], 2008, Australian Immunisation Handbook, V9th
[3]  
[Anonymous], 1998, FDN SOCIAL RES
[4]  
[Anonymous], 1999, WITHDRAWAL ROTAVIRUS, V48, P1007
[5]   The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety [J].
Baggs, James ;
Gee, Julianne ;
Lewis, Edwin ;
Fowler, Gabrielle ;
Benson, Patti ;
Lieu, Tracy ;
Naleway, Allison ;
Klein, Nicola P. ;
Baxter, Roger ;
Belongia, Edward ;
Glanz, Jason ;
Hambidge, Simon J. ;
Jacobsen, Steven J. ;
Jackson, Lisa ;
Nordin, Jim ;
Weintraub, Eric .
PEDIATRICS, 2011, 127 :S45-S53
[6]  
Bowling A., 2002, RES METHODS HLTH, V2nd
[7]  
Boyatzis R. E., 1998, TRANSFORMING QUALITA
[8]   In the heat of a signal: Responding to a vaccine safety signal for febrile seizures after 2010-11 influenza vaccine in young children, United States [J].
Broder, Karen R. ;
Martin, David B. ;
Vellozzi, Claudia .
VACCINE, 2012, 30 (11) :2032-2034
[9]  
Clothier HJ, 2011, COMMUN DIS INTELL, V35, P294
[10]  
Council for International Organizations of Medical Sciences, 2012, DEF APPL TERMS VACC